Brief: European Patent Office Informs PCI Biotech Of Intention To Grant New Patent
Sept 7 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* PCI BIOTECH: EUROPEAN PATENT FOR MRNA DELIVERY WITH
FIMANAC
* EUROPEAN PATENT OFFICE (EPO) HAS INFORMED PCI BIOTECH THAT
THEY
INTEND TO GRANT A NEW PATENT COVERING DELIVERY OF MRNA BY USE OF
PCI BIOTECH'S FIMANAC TECHNOLOGY
* EUROPEAN PATENT SECURES PROTECTION UNTIL 2039 AND THIS
PATENT
APPLICATION IS PENDING IN US AND KEY ASIAN MARKETS
Source text for Eikon: ID:nGNE8YcYgC
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process